第3回 UTOPIAシンポジウム

*Naoko Fujita¹, Adam Strange¹, Yuki Furuse¹ (1. The UTOPIA Center, The University of Tokyo (Japan))

*Jumpei Ito¹, Shusuke Kawakubo¹, Hiroaki Unno¹, Adam Strange¹, Spyros Lytras¹, Kaho Okumura¹, Alice Lilley², Ruth Harvey¹, Nicola Lewis², Kei Sato¹ (1. The Institute of Medical Science, The University of Tokyo (Japan), 2. Worldwide Influenza Centre, The Francis Crick Institute (UK))

*Shelyn Xu¹, Yutaka Matsuo¹ (1. Matsuo-Iwasawa Lab U-Tokyo (Japan))

*Keitaro Yamashita¹, Masahiro Hiraizumi², Hiroshi Nishimasu¹ (1. Research Center for Advanced Science and Technology (RCAST), The University of Tokyo (Japan), 2. Department of Chemistry & Biotechnology School of Engineering, The University of Tokyo (Japan))

*Yoshiaki Kise¹ (1. Department of Biological Sciences, The University of Tokyo (Japan))

*Kaiwen Liu¹, Kouji Kobiyama¹, Naoko Satoh-Takayama², Tomoya Hayashi¹, Burcu Temizoz¹, Hideo Negishi^1,3, Asuka Joy Tobuse¹, Mai Onaga¹, Areej Sakkour¹, Peter D Katsikis⁴, Cevayir Coban⁵, Ken J Ishii¹ (1. The Division of Vaccine Science, the Institute of Medical Science, the University of Tokyo (Japan), 2. Precision Immune Regulation RIKEN ECL Research Unit, RIKEN Center for Integrative Medical Sciences (Japan), 3. Laboratory of Immunology and Infection Control, Institute for Quantitative Biosciences, the University of Tokyo (Japan), 4. Department of Immunology, Erasmus University Medical Center (Netherlands), 5. Division of Malaria Immunology, the Institute of Medical Science, the University of Tokyo (Japan))

Kouji Kobiyama^1,2, Daichi Utsumi³, Yu Kaku⁴, Eita Sasaki⁵, Fumihiko Yasui⁶, Tomotaka Okamura³, Asuka Joy Tobuse^1,12, Areej Sakkour¹, Ahmad Faisal Amiry⁶, *Tomoya Hayashi¹, Burcu Temizoz¹, Kaiwen Liu¹, Hideo Negishi¹, Noriko Toyama-Sorimachi^2,7, Michinori Kohara⁶, Tatsuya Sawasaki⁸, Junichi Takagi⁹, Kei Sato^{2,4,10,11,12,13,14}, Yoshimasa Takahashi⁵, Yasuhiro Yasutomi³, Ken J Ishii^1,2,11,12,15 (1. Division of Vaccine Science, The Institute of Medical Science, The University of Tokyo (Japan), 2. International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo (Japan), 3. Laboratory of Immunoregulation and Vaccine Research, Tsukuba Primate Research Center, National Institutes of Biomedical Innovation, Health and Nutrition (Japan), 4. Division of Systems Virology, The Institute of Medical Science, The University of Tokyo (Japan), 5. Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases (Japan), 6. Department of Microbiology and Cell Biology, Tokyo Metropolitan Institute of Medical Science (Japan), 7. Division of Human Immunology, International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo (Japan), 8. Proteo-Science Center (PROS), Ehime University (Japan), 9. Laboratory for Protein Synthesis and Expression, Institute for Protein Research, Osaka University (Japan), 10. International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo (Japan), 11. Graduate School of Medicine, The University of Tokyo (Japan), 12. Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo (Japan), 13. Collaboration Unit for Infection, Joint Research Center for Human Retrovirus Infection, Kumamoto University (Japan), 14. MRC-University of Glasgow Centre for Virus Research (UK), 15. The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo (Japan))

*SUQI WANG¹, Ryunosuke MURO², Taku KUREHA¹, Takeshi NITTA², Hiroshi TAKAYANAGI¹ (1. Department of Immunology, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo (Japan), 2. Division of Molecular Pathology, Research Institute for Biomedical Sciences, Tokyo University of Science (Japan))

*Satoshi Hashimoto¹, Aoi SATOH^3,4, Jiahuan ZENG¹, Jennifer SAUERLAND², Hideaki TAKEDA¹, Hotaka KOBAYASHI^3,4, Toshifumi INADA¹ (1. Division of RNA and Gene Regulation The Institute of Medical Science, The University of Tokyo (Japan), 2. University of Heidelberg (Germany), 3. Institute of Advanced Medical Sciences, Tokushima University, Division of Gene Regulation (Japan), 4. Institute for Quantitative Biosciences, The University of Tokyo, Laboratory of mRNA Translation (Japan))

*Yuji Kubota¹, Mutsuhiro Takekawa¹ (1. Division of Cell Signaling and Molecular Medicine, Institute of Medical Science, The University of Tokyo (Japan))

*Daisuke Sugiura¹, Hidetaka Kosako², Taku Okazaki¹ (1. Laboratory of Molecular Immunology, Institute for Quantitative Biosciences, The University of Tokyo (Japan), 2. Division of Cell Signaling, Fujii Memorial Institute of Medical Sciences, Institute of Advanced Medical Sciences, Tokushima University (Japan))

*Yoshimi Imawari¹, Sae Aratani¹, Hiroshi Ueki¹, Naoko Iwata², Noriyo Nagata ², Yoshihiro Kawaoka¹, Makoto Nakanishi¹ (1. Institute of Medical Science, University of Tokyo (Japan), 2. National Institute of Infectious Diseases (Japan))

*Akinori Kanai¹, Yasuhiko Haga¹, Yukie Kashima¹, Ayako Suzuki¹, Yutaka Suzuki¹ (1. Graduate School of Frontier Sciences, The University of Tokyo (Japan))

*Hotaka Kobayashi^1,2 (1. IQB, The University of Tokyo (Japan), 2. IAMS, Tokushima University (Japan))

*Koji Hashimoto¹ (1. Graduate School of Arts and Sciences, The University of Tokyo (Japan))

*Waki Toya¹, Masahiro Kitao², Yusuke Inoue³, Kaori Muto¹ (1. The Institute of Medical Science, The University of Tokyo (Japan), 2. Institute of Business Sciences, University of Tsukuba (Japan), 3. School of Public Health, Kyoto University (Japan))

*Chihiro NISHI¹, Kaori Muto¹ (1. Department of Public Policy, The institute of Medical Science, The University of Tokyo (Japan))

*Masakaze Hamada¹, Junna Kawasaki², Ryo Komorizono¹, Naoko Fujita¹, Mie Kobayashi-Ishihara¹, Yuki Furuse¹ (1. Department of Microbiology and Infection, The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo, Tokyo (Japan), 2. Department of Infectious Disease Pathobiology, Graduate School of Medicine, Chiba University, Chiba (Japan))